ConductScience.org, home

Gene · 1294

Papers2,575

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Prime Editing Driven Functional Genomics: Bridging Genotype to Phenotype in the Post-Genomic Era.Int J Mol Sci202641751840PubTator, text miningPubMed
Identification of Paraptosis-Related Renal Cell Carcinoma Subtypes, Construction of a Prognostic Signature, and Determination of Tumor Microenvironment Landscape Using Bioinformatic Analysis and Experimental Verification.
Curr Issues Mol Biol202641751495PubTator, text miningPubMed
Integrative transcriptomic and experimental analysis identifies collagen-associated hub genes bridging chronic hypersensitivity pneumonitis and lung cancer.Comput Biol Chem202641734664PubTator, text miningPubMed
Advances in Engineered Virus-Like Particles for Genome Editing and Therapy.BioDrugs202641733889PubTator, text miningPubMed
In vivo confocal microscopic evaluation of patients with epidermolysis bullosa demonstrates severe loss of corneal nerves.Am J Ophthalmol Case Rep202641716620PubTator, text miningPubMed
Addressing the diagnostic gap through deep phenotyping.Hum Genomics202641715217PubTator, text miningPubMed
Distinct mutations in the autoimmune regulator gene differentially affect transcriptional and functional properties of medullary thymic epithelial cells.Hum Mol Genet202641686483PubTator, text miningPubMed
Dominant Dystrophic Epidermolysis Bullosa with COL7A1 Variant Confirmed by Whole-Exome Sequencing in a Chinese Family and Genotype-Phenotype Correlation Analysis.Mol Syndromol202641675682PubTator, text miningPubMed
A block staining method using ethanolic phosphotungstic acid for the visualisation of collagens in transmission electron microscopy.PLoS One202641666163PubTator, text miningPubMed
Amelioration of Dominant Dystrophic Epidermolysis Bullosa Ulceration by Combination Gentian Violet and Trichloroacetic Acid Therapy.J Drugs Dermatol202641642131PubTator, text miningPubMed
A systems biology framework uncovers multi-level genetic regulation of dizziness/vertigo through eQTL-GWAS integration and single-cell analysis.Int J Neurosci202641640369PubTator, text miningPubMed
Genotype-Phenotype Correlations in Recessive Dystrophic Epidermolysis Bullosa: A Systematic Review.JAMA Dermatol202641637086PubTator, text miningPubMed
Multiomic analysis of colorectal adenocarcinoma reveals a new subtype of myofibroblastic cancer-associated fibroblasts that express high levels of B7-H3 and have poor-prognosis value.J Immunother Cancer202641629132PubTator, text miningPubMed
Collagen expression downregulation and intestinal barrier impairment are associated with severe clinical phenotypes in very early-onset inflammatory bowel disease.Rev Esp Enferm Dig202641569120PubTator, text miningPubMed
Construction of biomimetic gradient-structured cartilage organoids and mechanistic study of their application for cartilage rejuvenation.Bioact Mater202641551764PubTator, text miningPubMed
Proteomic mapping of human Tenon's fascia reveals its biomimetic potential for corneal stromal extracellular matrix reconstruction.Exp Eye Res202641478390PubTator, text miningPubMed
Spherical Skin Model: Stratified Co-Culture of Fibroblasts and Keratinocytes on Spherical Beads Toward Compound Screening.Adv Healthc Mater202641387267PubTator, text miningPubMed
Base edited skin equivalents with clinical potential for ex vivo correction of recessive dystrophic epidermolysis bullosa.Mol Ther202641254941PubTator, text miningPubMed
Positive predictive values of enzyme-linked immunosorbent assay (ELISA) for antienvoplakin and anticollagen VII antibodies: Results from 4 centers from Spain.J Am Acad Dermatol202641167276PubTator, text miningPubMed
A novel variant c.A527G in ITGB4 leads to autosomal dominant epidermolysis bullosa in China.Front Med (Lausanne)202541728014PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/1294/papers?page=3